| 2340 |
당뇨병/비만/지질 |
|
Real-World Analysis of Rapid-Acting Insulin Analog Use and Its Blood Glucose Lowering Effect in Patients with Type 2 Diabetes Mellitus: Results from PASSION Disease Registry in Korea.
|
Jae Hyoung Cho,Soon Jib Yoo,Keun Gyu Park,Ho Sang Shon,Hak Chul Jang,Choon Hee Chung,Jeong Hyun Park,Jae Myung Yu |
Diabetes, metabolic syndrome and obesity : targets and therapy |
2022/00 |
| 2339 |
당뇨병/비만/지질 |
|
Novel Glycemic Index Based on Continuous Glucose Monitoring to Predict Poor Clinical Outcomes in Critically Ill Patients: A Pilot Study.
|
Ha Eun Yeong,Chung Seung Min,Moon Jun Sung |
Frontiers in endocrinology |
2022/00 |
| 2338 |
당뇨병/비만/지질 |
|
Association Between Fat Mass or Fat Fibrotic Gene Expression and Polyneuropathy in Subjects With Obesity: A Korean Metabolic Bariatric Surgery Cohort.
|
Tae Jung Oh,Choi Sung Hee,Hak Chul Jang |
Frontiers in endocrinology |
2022/00 |
| 2337 |
당뇨병/비만/지질 |
|
Metabolic Stress Index Including Mitochondrial Biomarker for Noninvasive Diagnosis of Hepatic Steatosis.
|
Ji Hye Huh |
Frontiers in endocrinology |
2022/00 |
| 2336 |
당뇨병/비만/지질 |
|
Free Versus Fixed-Ratio Combination of Basal Insulin and GLP-1 Receptor Agonists in Type 2 Diabetes Uncontrolled With GLP-1 Receptor Agonists: A Systematic Review and Indirect Treatment Comparison.
|
Jung Han Na,Hwi Seung Kim,Se Hee Min,Chang Hee Jung,Joong Yeol Park,Yun Kyung Cho |
Frontiers in endocrinology |
2022/00 |
| 2335 |
당뇨병/비만/지질 |
|
Body Mass Index Changes and Insulin Resistance at Age 4: A Prospective Cohort Study.
|
Young Ah Lee,Shin Choong Ho,Lee Hye Jin |
Frontiers in endocrinology |
2022/00 |
| 2334 |
당뇨병/비만/지질 |
|
Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy.
|
Byung Wan Lee,Eun Seok Kang,Bong Soo Cha,Ji Hye Huh |
Frontiers in endocrinology |
2022/00 |
| 2333 |
당뇨병/비만/지질 |
|
Metabolic Syndrome as a Risk Factor of Endometrial Cancer: A Nationwide Population-Based Cohort Study of 2.8 Million Women in South Korea.
|
Kyung Do Han |
Frontiers in oncology |
2022/00 |
LOGIN
JOIN
English
